Close this search box.

Hang on, they only tested this on how many people?

Moderna has begun clinical trials for a new flu vaccine that will use the same mRNA technology that was in the Covid vaccine. They will trial this drug on 50 people.

Fifty is not a very impressive number for a clinical trial but it doesn’t matter to the UK government, which has gone full-steam ahead with an order for at least 250 million vaccines per year from Moderna. The deal includes the construction of a new vaccine factory.

Moderna’s clinical trials in the U.S. will follow these 50 participants for up to 1 year but not longer than that.

Question: Does it feel like they are purposely not making these studies robust? See Dr. John Campbell’s take on the matter here.

Related Articles

Join the mailing list

Get the daily email that makes reading the investment news actually enjoyable.

Related Articles

Redacted is an independent platform, unencumbered by external factors or restrictive policies, on which Clayton and Natali Morris bring you quality information, balanced reporting, constructive debate, and thoughtful narratives.